寶馨科技(002514.SZ):轉讓方與鹽高新簽署股權轉讓事宜之終止協議
格隆匯 9 月 7日丨寶馨科技(002514.SZ)公佈,轉讓方與鹽高新於2020年9月7日簽署了《陳東、汪敏、朱永福、蘇州永福投資有限公司和鹽城高新區投資集團有限公司股權轉讓事宜之終止協議》。
因未獲得江蘇省國有資產監督管理委員會的批准,股權轉讓事宜終止。經轉受讓雙方協商一致,同意解除上述《股權轉讓框架協議》,終止本次收購,因股權及控制權轉讓簽訂的一系列協議終止並解除。轉受讓雙方於2020年9月7日簽署了《陳東、汪敏、朱永福、蘇州永福投資有限公司和鹽城高新區投資集團有限公司股權轉讓事宜之終止協議》,轉讓方前期收到的5000萬元人民幣履約保證金予以退還給鹽高新。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.